Veeva SystemsLTS:0LO3 83 EV-to-FCF is 14.47 as of Jul. 06, 2026, which is 64% below its 10-year median of 40.18. GuruFocus rates LTS:0LO3 with a GF Score™ of 83/100 and a GF Value™ of $283.40 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 405 Healthcare Providers & Services companies, Veeva Systems ranks better than 58.27% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Veeva Systems's Enterprise Value is $24,100 Mil.
Veeva Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 was $1,665 Mil. Therefore, Veeva Systems's EV-to-FCF for today is 14.47.
The historical rank and industry rank for Veeva Systems's EV-to-FCF or its related term are showing as below:
LTS:0LO3'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.95 Med: 40.18 Max: 114.02
Current: 14.47
During the past 13 years, the highest EV-to-FCF of Veeva Systems was 114.02. The lowest was 10.95. And the median was 40.18.
LTS:0LO3's EV-to-FCF is ranked better than 58.27% of 405
companies
in the Healthcare Providers & Services industry
Industry Median: 17.97
vs LTS:0LO3: 14.47
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Veeva Systems's PE Ratio (TTM) for today is calculated as:
Veeva Systems's share price for today is $190.94.
Veeva Systems's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $5.610.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Veeva Systems EV-to-FCF Related Terms
Veeva Systems EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Veeva Systems's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Veeva Systems's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Veeva Systems EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Veeva Systems's EV-to-FCF falls into.
Veeva Systems's current Enterprise Value is $24,100 Mil.
Veeva Systems's Free Cash Flow for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,665 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Veeva Systems (LTS:0LO3) has a EV-to-FCF of 14.47 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Veeva Systems and its competitors. This is 64% below median its historical median of 40.18. Over the past decade, Veeva Systems' EV-to-FCF has ranged from 10.95 to 114.02. According to the industry distribution chart, Veeva Systems ranks #169 out of 405 companies in the Healthcare Providers & Services industry, placing it in the top 41.7%.
Is Veeva Systems' EV-to-FCF too high?
Veeva Systems' current EV-to-FCF of 14.47 is 64% below median its 10-year median of 40.18. Over the past 10 years, this metric has ranged from a low of 10.95 to a high of 114.02. The Healthcare Providers & Services industry median EV-to-FCF is 17.97. Veeva Systems' value of 14.47 is 19.5% below this industry median. Based on the distribution chart, Veeva Systems ranks #169 out of 405 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Veeva Systems has a GF Score™ of 83/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' EV-to-FCF compare to BTSG and TEM?
According to the Healthcare Providers & Services industry distribution chart, Veeva Systems ranks #169 out of 405 companies for EV-to-FCF. This puts Veeva Systems in the upper half of its industry. The industry median EV-to-FCF is 17.97. Veeva Systems' value of 14.47 is 19.5% below this benchmark. Historically, Veeva Systems' own EV-to-FCF has ranged from 10.95 to 114.02 over the past decade. While the company's 10-year median is 40.18 vs. the industry median of 17.97, Veeva Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.97, based on 405 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Veeva Systems's current EV-to-FCF of 14.47 is 19.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Veeva Systems and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Veeva Systems's current EV-to-FCF is 14.47, which is 64% below median its own 10-year median of 40.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (LTS:0LO3) is currently considered Significantly Undervalued. The stock's GF Value™ is $283.40, compared to a current price of $190.94 — trading 32.6% below its estimated fair value. The current EV-to-FCF is 14.47, which is 64% below median its 10-year median of 40.18 and 19.5% below the Healthcare Providers & Services industry median of 17.97. Veeva Systems' overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Veeva Systems (LTS:0LO3), the current EV-to-FCF is 14.47 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Veeva Systems (LTS:0LO3) Overvalued in 2026?
Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued.
The current stock price of $190.94 is trading 32.6% below its estimated GF Value™ of $283.40.
GuruFocus considers Veeva Systems to be Significantly Undervalued.
Key valuation signals for LTS:0LO3:
EV-to-FCF: 14.47 (64% below median its 10-year median of 40.18)
GF Value™: $283.40 vs. price of $190.94 (32.6% below fair value)
Industry Position: 19.5% below the Healthcare Providers & Services median (#169 of 405)
No single metric tells the full story. See the LTS:0LO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
83GF Score
Get the complete analysis for LTS:0LO3
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0LO3 has been successfully added to your 
